The history of Sildenafil presents a complex picture for those considering investment. While the initial launch generated massive profits, the end of its exclusive rights opened the avenue to generic versions, dramatically reducing market share. This presents a particular challenge for firms banking on related blockbuster offerings, suggesting that

The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in revenue , its patent expiration created a wave of knock-off medications, significantly impacting its position . While specific firms may try to capitalize on male sexual dysfunction, the existing land